Page last updated: 2024-10-27

fluoxetine and Plasmodium falciparum Malaria

fluoxetine has been researched along with Plasmodium falciparum Malaria in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khairul, MF1
Min, TH1
Low, JH1
Nasriyyah, CH1
A'shikin, AN1
Norazmi, MN1
Ravichandran, M1
Raju, SS1

Other Studies

1 other study available for fluoxetine and Plasmodium falciparum Malaria

ArticleYear
Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
    Japanese journal of infectious diseases, 2006, Volume: 59, Issue:5

    Topics: Animals; Antimalarials; Cells, Cultured; Chloroquine; Drug Resistance, Multiple; Drug Synergism; Ery

2006